Fluorine in PDB 5a0c: Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Enzymatic activity of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
All present enzymatic activity of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor:
3.4.21.37;
Protein crystallography data
The structure of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor, PDB code: 5a0c
was solved by
F.Vonnussbaum,
V.M.-J.Li,
S.Allerheiligen,
S.Anlauf,
L.Baerfacker,
M.Bechem,
M.Delbeck,
M.F.Fitzgerald,
M.Gerisch,
H.Gielen-Haertwig,
H.Haning,
D.Karthaus,
D.Lang,
K.Lustig,
D.Meibom,
J.Mittendorf,
U.Rosentreter,
M.Schaefer,
S.Schaefer,
J.Schamberger,
L.A.Telan,
A.Tersteegen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
38.29 /
2.10
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
71.517,
71.517,
97.400,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.3 /
21.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
(pdb code 5a0c). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor, PDB code: 5a0c:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 1 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:16.2
occ:1.00
|
F20
|
A:JJV1001
|
0.0
|
16.2
|
1.0
|
C18
|
A:JJV1001
|
1.3
|
16.2
|
1.0
|
F21
|
A:JJV1001
|
2.1
|
17.1
|
1.0
|
F19
|
A:JJV1001
|
2.2
|
16.4
|
1.0
|
C15
|
A:JJV1001
|
2.4
|
15.9
|
1.0
|
C17
|
A:JJV1001
|
2.8
|
16.1
|
1.0
|
CG2
|
A:VAL197
|
3.3
|
17.6
|
1.0
|
N
|
A:SER202
|
3.4
|
15.7
|
1.0
|
O
|
A:CYS198
|
3.5
|
13.9
|
1.0
|
C13
|
A:JJV1001
|
3.6
|
15.6
|
1.0
|
CB
|
A:ALA220
|
3.7
|
15.8
|
1.0
|
C
|
A:ASP201
|
3.7
|
16.2
|
1.0
|
CB
|
A:VAL197
|
3.7
|
17.3
|
1.0
|
CA
|
A:SER202
|
3.8
|
15.8
|
1.0
|
CB
|
A:ASP201
|
3.9
|
15.8
|
1.0
|
OG
|
A:SER202
|
4.0
|
15.6
|
1.0
|
O
|
A:ASP201
|
4.1
|
16.3
|
1.0
|
C16
|
A:JJV1001
|
4.2
|
16.6
|
1.0
|
C
|
A:CYS198
|
4.3
|
15.0
|
1.0
|
CA
|
A:ASP201
|
4.3
|
15.7
|
1.0
|
N
|
A:CYS198
|
4.3
|
15.8
|
1.0
|
C
|
A:ALA220
|
4.5
|
15.0
|
1.0
|
CB
|
A:SER202
|
4.6
|
15.5
|
1.0
|
C
|
A:VAL197
|
4.6
|
16.3
|
1.0
|
CA
|
A:ALA220
|
4.6
|
15.2
|
1.0
|
N
|
A:ASP201
|
4.7
|
15.6
|
1.0
|
CG1
|
A:VAL197
|
4.7
|
18.4
|
1.0
|
N
|
A:SER221
|
4.7
|
14.5
|
1.0
|
CA
|
A:CYS198
|
4.8
|
15.5
|
1.0
|
O
|
A:ALA220
|
4.8
|
14.9
|
1.0
|
C12
|
A:JJV1001
|
4.8
|
15.0
|
1.0
|
CA
|
A:VAL197
|
4.8
|
16.5
|
1.0
|
C14
|
A:JJV1001
|
5.0
|
15.5
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 2 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:17.1
occ:1.00
|
F21
|
A:JJV1001
|
0.0
|
17.1
|
1.0
|
C18
|
A:JJV1001
|
1.3
|
16.2
|
1.0
|
F20
|
A:JJV1001
|
2.1
|
16.2
|
1.0
|
F19
|
A:JJV1001
|
2.1
|
16.4
|
1.0
|
C15
|
A:JJV1001
|
2.4
|
15.9
|
1.0
|
C17
|
A:JJV1001
|
3.2
|
16.1
|
1.0
|
C13
|
A:JJV1001
|
3.3
|
15.6
|
1.0
|
CG2
|
A:VAL197
|
3.3
|
17.6
|
1.0
|
N
|
A:PHE222
|
3.3
|
14.3
|
1.0
|
C
|
A:SER221
|
3.5
|
14.4
|
1.0
|
N
|
A:SER221
|
3.6
|
14.5
|
1.0
|
CA
|
A:PHE222
|
3.6
|
14.7
|
1.0
|
C
|
A:PHE222
|
3.6
|
15.4
|
1.0
|
O
|
A:PHE222
|
3.8
|
16.1
|
1.0
|
C
|
A:ALA220
|
3.9
|
15.0
|
1.0
|
O
|
A:SER221
|
3.9
|
13.5
|
1.0
|
CB
|
A:ALA220
|
4.0
|
15.8
|
1.0
|
CG1
|
A:VAL223
|
4.1
|
16.2
|
1.0
|
CA
|
A:SER221
|
4.1
|
14.8
|
1.0
|
N
|
A:VAL223
|
4.2
|
14.9
|
1.0
|
CA
|
A:ALA220
|
4.3
|
15.2
|
1.0
|
O
|
A:ALA236
|
4.3
|
15.2
|
1.0
|
CB
|
A:VAL197
|
4.4
|
17.3
|
1.0
|
C16
|
A:JJV1001
|
4.4
|
16.6
|
1.0
|
C12
|
A:JJV1001
|
4.5
|
15.0
|
1.0
|
O
|
A:ALA220
|
4.6
|
14.9
|
1.0
|
C14
|
A:JJV1001
|
5.0
|
15.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 3 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:16.4
occ:1.00
|
F19
|
A:JJV1001
|
0.0
|
16.4
|
1.0
|
C18
|
A:JJV1001
|
1.3
|
16.2
|
1.0
|
F21
|
A:JJV1001
|
2.1
|
17.1
|
1.0
|
F20
|
A:JJV1001
|
2.2
|
16.2
|
1.0
|
C15
|
A:JJV1001
|
2.4
|
15.9
|
1.0
|
C13
|
A:JJV1001
|
2.9
|
15.6
|
1.0
|
C
|
A:ALA220
|
3.1
|
15.0
|
1.0
|
O
|
A:ALA220
|
3.2
|
14.9
|
1.0
|
OG
|
A:SER202
|
3.2
|
15.6
|
1.0
|
O
|
A:SER221
|
3.2
|
13.5
|
1.0
|
C
|
A:SER221
|
3.2
|
14.4
|
1.0
|
N
|
A:SER221
|
3.3
|
14.5
|
1.0
|
CA
|
A:SER202
|
3.3
|
15.8
|
1.0
|
CA
|
A:SER221
|
3.6
|
14.8
|
1.0
|
CE1
|
A:HIS57
|
3.6
|
16.0
|
1.0
|
C17
|
A:JJV1001
|
3.7
|
16.1
|
1.0
|
CB
|
A:ALA220
|
3.7
|
15.8
|
1.0
|
CB
|
A:SER202
|
3.7
|
15.5
|
1.0
|
N
|
A:SER202
|
3.8
|
15.7
|
1.0
|
N
|
A:PHE222
|
3.8
|
14.3
|
1.0
|
NE2
|
A:HIS57
|
3.9
|
15.8
|
1.0
|
CA
|
A:ALA220
|
4.0
|
15.2
|
1.0
|
C12
|
A:JJV1001
|
4.3
|
15.0
|
1.0
|
CA
|
A:PHE222
|
4.4
|
14.7
|
1.0
|
C
|
A:ASP201
|
4.5
|
16.2
|
1.0
|
C
|
A:SER202
|
4.5
|
15.3
|
1.0
|
N
|
A:GLY203
|
4.6
|
15.1
|
1.0
|
O
|
A:ASP201
|
4.7
|
16.3
|
1.0
|
C16
|
A:JJV1001
|
4.8
|
16.6
|
1.0
|
ND1
|
A:HIS57
|
4.9
|
16.6
|
1.0
|
CG2
|
A:VAL197
|
4.9
|
17.6
|
1.0
|
C
|
A:PHE222
|
5.0
|
15.4
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 4 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:15.5
occ:1.00
|
F20
|
B:JJV1001
|
0.0
|
15.5
|
1.0
|
C18
|
B:JJV1001
|
1.4
|
15.6
|
1.0
|
F21
|
B:JJV1001
|
2.1
|
16.2
|
1.0
|
F19
|
B:JJV1001
|
2.2
|
15.9
|
1.0
|
C15
|
B:JJV1001
|
2.4
|
15.2
|
1.0
|
C17
|
B:JJV1001
|
2.9
|
15.4
|
1.0
|
N
|
B:SER202
|
3.2
|
14.6
|
1.0
|
CG2
|
B:VAL197
|
3.4
|
18.0
|
1.0
|
O
|
B:CYS198
|
3.5
|
13.9
|
1.0
|
CB
|
B:ALA220
|
3.5
|
15.6
|
1.0
|
C
|
B:ASP201
|
3.6
|
15.3
|
1.0
|
CA
|
B:SER202
|
3.6
|
14.9
|
1.0
|
C13
|
B:JJV1001
|
3.7
|
14.7
|
1.0
|
CB
|
B:ASP201
|
3.7
|
14.6
|
1.0
|
CB
|
B:VAL197
|
3.8
|
17.7
|
1.0
|
OG
|
B:SER202
|
4.0
|
14.1
|
1.0
|
O
|
B:ASP201
|
4.0
|
14.9
|
1.0
|
CA
|
B:ASP201
|
4.2
|
14.6
|
1.0
|
C16
|
B:JJV1001
|
4.2
|
15.4
|
1.0
|
N
|
B:CYS198
|
4.3
|
16.1
|
1.0
|
C
|
B:CYS198
|
4.3
|
15.0
|
1.0
|
CB
|
B:SER202
|
4.4
|
14.5
|
1.0
|
C
|
B:ALA220
|
4.4
|
15.3
|
1.0
|
CA
|
B:ALA220
|
4.5
|
15.4
|
1.0
|
N
|
B:ASP201
|
4.5
|
15.0
|
1.0
|
C
|
B:VAL197
|
4.6
|
16.2
|
1.0
|
O
|
B:ALA220
|
4.7
|
15.8
|
1.0
|
CG1
|
B:VAL197
|
4.7
|
18.7
|
1.0
|
N
|
B:SER221
|
4.7
|
15.2
|
1.0
|
CA
|
B:CYS198
|
4.8
|
16.0
|
1.0
|
CA
|
B:VAL197
|
4.8
|
16.4
|
1.0
|
C12
|
B:JJV1001
|
4.8
|
14.1
|
1.0
|
C
|
B:SER202
|
4.9
|
14.5
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 5 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:16.2
occ:1.00
|
F21
|
B:JJV1001
|
0.0
|
16.2
|
1.0
|
C18
|
B:JJV1001
|
1.3
|
15.6
|
1.0
|
F20
|
B:JJV1001
|
2.1
|
15.5
|
1.0
|
F19
|
B:JJV1001
|
2.1
|
15.9
|
1.0
|
C15
|
B:JJV1001
|
2.3
|
15.2
|
1.0
|
C17
|
B:JJV1001
|
3.1
|
15.4
|
1.0
|
CG2
|
B:VAL197
|
3.2
|
18.0
|
1.0
|
C13
|
B:JJV1001
|
3.2
|
14.7
|
1.0
|
N
|
B:PHE222
|
3.4
|
14.7
|
1.0
|
C
|
B:SER221
|
3.6
|
14.6
|
1.0
|
N
|
B:SER221
|
3.6
|
15.2
|
1.0
|
CA
|
B:PHE222
|
3.7
|
14.8
|
1.0
|
C
|
B:PHE222
|
3.7
|
15.8
|
1.0
|
CB
|
B:ALA220
|
3.9
|
15.6
|
1.0
|
C
|
B:ALA220
|
3.9
|
15.3
|
1.0
|
O
|
B:PHE222
|
3.9
|
16.1
|
1.0
|
CG1
|
B:VAL223
|
4.0
|
16.2
|
1.0
|
O
|
B:SER221
|
4.0
|
14.6
|
1.0
|
CA
|
B:SER221
|
4.1
|
14.7
|
1.0
|
N
|
B:VAL223
|
4.3
|
15.9
|
1.0
|
CA
|
B:ALA220
|
4.3
|
15.4
|
1.0
|
CB
|
B:VAL197
|
4.3
|
17.7
|
1.0
|
C16
|
B:JJV1001
|
4.3
|
15.4
|
1.0
|
O
|
B:ALA236
|
4.4
|
15.3
|
1.0
|
C12
|
B:JJV1001
|
4.5
|
14.1
|
1.0
|
O
|
B:ALA220
|
4.6
|
15.8
|
1.0
|
C14
|
B:JJV1001
|
4.9
|
14.6
|
1.0
|
OG
|
B:SER202
|
5.0
|
14.1
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5a0c
Go back to
Fluorine Binding Sites List in 5a0c
Fluorine binding site 6 out
of 6 in the Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Human Neutrophil Elastase in Complex with A Dihydropyrimidone Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1001
b:15.9
occ:1.00
|
F19
|
B:JJV1001
|
0.0
|
15.9
|
1.0
|
C18
|
B:JJV1001
|
1.3
|
15.6
|
1.0
|
F21
|
B:JJV1001
|
2.1
|
16.2
|
1.0
|
F20
|
B:JJV1001
|
2.2
|
15.5
|
1.0
|
C15
|
B:JJV1001
|
2.4
|
15.2
|
1.0
|
C13
|
B:JJV1001
|
2.9
|
14.7
|
1.0
|
C
|
B:ALA220
|
3.1
|
15.3
|
1.0
|
O
|
B:ALA220
|
3.2
|
15.8
|
1.0
|
OG
|
B:SER202
|
3.2
|
14.1
|
1.0
|
C
|
B:SER221
|
3.2
|
14.6
|
1.0
|
N
|
B:SER221
|
3.2
|
15.2
|
1.0
|
O
|
B:SER221
|
3.2
|
14.6
|
1.0
|
CA
|
B:SER202
|
3.3
|
14.9
|
1.0
|
CA
|
B:SER221
|
3.5
|
14.7
|
1.0
|
CB
|
B:SER202
|
3.6
|
14.5
|
1.0
|
CE1
|
B:HIS57
|
3.7
|
14.9
|
1.0
|
CB
|
B:ALA220
|
3.7
|
15.6
|
1.0
|
C17
|
B:JJV1001
|
3.7
|
15.4
|
1.0
|
N
|
B:SER202
|
3.8
|
14.6
|
1.0
|
N
|
B:PHE222
|
3.8
|
14.7
|
1.0
|
NE2
|
B:HIS57
|
3.9
|
14.7
|
1.0
|
CA
|
B:ALA220
|
3.9
|
15.4
|
1.0
|
C12
|
B:JJV1001
|
4.3
|
14.1
|
1.0
|
CA
|
B:PHE222
|
4.4
|
14.8
|
1.0
|
C
|
B:SER202
|
4.5
|
14.5
|
1.0
|
N
|
B:GLY203
|
4.5
|
14.6
|
1.0
|
C
|
B:ASP201
|
4.6
|
15.3
|
1.0
|
O
|
B:ASP201
|
4.8
|
14.9
|
1.0
|
C16
|
B:JJV1001
|
4.8
|
15.4
|
1.0
|
ND1
|
B:HIS57
|
4.9
|
15.3
|
1.0
|
CG2
|
B:VAL197
|
4.9
|
18.0
|
1.0
|
|
Reference:
F.Von Nussbaum,
V.M.Li,
S.Allerheiligen,
S.Anlauf,
L.Barfacker,
M.Bechem,
M.Delbeck,
M.F.Fitzgerald,
M.Gerisch,
H.Gielen-Haertwig,
H.Haning,
D.Karthaus,
D.Lang,
K.Lustig,
D.Meibom,
J.Mittendorf,
U.Rosentreter,
M.Schafer,
S.Schafer,
J.Schamberger,
L.A.Telan,
A.Tersteegen.
Freezing the Bioactive Conformation to Boost Potency: the Identification of Bay 85-8501, A Selective and Potent Inhibitor of Human Neutrophil Elastase For Pulmonary Diseases. Chemmedchem V. 10 1163 2015.
ISSN: ESSN 1860-7187
PubMed: 26083237
DOI: 10.1002/CMDC.201500131
Page generated: Thu Aug 1 07:34:19 2024
|